A clinical trial examining vasoactive intestinal peptide alongside other biological markers in migraine was registered with a status update dated September 21, 2026. The trial, titled "Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine," is listed on ClinicalTrials.gov under identifier NCT07832032. According to the registry, the study status is currently listed as not yet recruiting. No phase information was provided in the available record. The trial appears designed to investigate biological profiles that include neuropeptides, neurotrophins, and miRNA in the context of migraine, based on the study title. No further details on study design, enrollment criteria, or anticipated timelines were included in this update. As the trial has not yet begun recruiting participants, no results or interim data are available at this time. Updates on recruitment status and study progress would be expected to appear in future registry entries. Readers interested in vasoactive intestinal peptide can consult the compound overview for additional background and regulatory context.
Trial on VIP, Neuropeptides, Neurotrophins in Migraine Not Yet Recruiting
See the full vasoactive intestinal peptide overview
Source: https://clinicaltrials.gov/study/NCT07832032